down arrow

Albert David

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE155C01010
  • NSEID: ALBERTDAVD
  • BSEID: 524075
INR
796.45
26.1 (3.39%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 4.21 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Albert David Ltd stock-summary
stock-summary
Albert David Ltd
Micro Cap
Pharmaceuticals & Drugs
Albert David Limited (ADL), a Unit of Kothari Group, was incorporated in 1938 at Calcutta. The Company belongs to a renowned industrial house of Kolkata, the "Kothari Group". The Company's principal business is manufacturing and trading of Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms and Bulk Drugs by way of domestic sale or export. Apart from these, it manufactures disposable syringes and needles and a wide range of bulk drugs.
Company Coordinates stock-summary
Company Details
D Block 3rd Flr Gillander Hous, Netaji Subhas Road Kolkata West Bengal : 700001
stock-summary
Tel: 91-33-22302330/2262 8436/8456/
stock-summary
adidavid@dataone.in
Registrar Details
Maheshwari Datamatics Pvt Ltd , 6 Mangoe Lane , 2nd Floor, Calcutta
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR None Cr
Number of Shares
None Cr
Face Value
INR None
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 1 Schemes (0.01%)

FIIs

Held by 9 FIIs (0.86%)

Promoter with highest holding

Kothari Investment And Industries Private Limited (41.36%)

Highest Public shareholder

General Insurance Corporation Of India (1.61%)

Individual Investors Holdings

27.92%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
A K Kothari
Executive Chairman
2.09 cr
Hemal Kampani
Independent Director
3.95 lacs
Rajiv Singhi
Independent Director
3.85 lacs
Prabhawati Devi Kothari
Director
2.95 lacs
Arindam Sarkar
Independent Director
2.25 lacs
Shirish Gundopant Belapure
Independent Director
2.8 lacs
Monjori Mitra
Independent Director
1.85 lacs
Anand Vardhan Kothari
Director
1.75 lacs
A B Chakrabarty
Company Sec. & Compli. Officer
0
U. M. Kunte
Managing Director & CEO
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharmaceutical
312.70
98.58%
Other Operating Revenues - Export Incentive
2.32
0.73%
Other Operating Revenues - Miscellaneous Sales
1.87
0.59%
 
98.58
Pharmaceutical
1.42
Pharmaceutical
0.73
Other Operating Revenues - Export Incentive
99.27
Other Operating Revenues - Export Incentive
0.59
Other Operating Revenues - Miscellaneous Sales
99.41
Other Operating Revenues - Miscellaneous Sales
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
83 Cr
(Quarterly Results - Dec 2024)
Net Profit:
-9 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 455 Cr (Micro Cap)

stock-summary
P/E

11.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

1.49%

stock-summary
Debt Equity

-0.74

stock-summary
Return on Equity

10.56%

stock-summary
Price to Book

1.15